Mast cell infiltration associated with tubulointerstitial fibrosis in chronic Aristolochic Acid Nephropathy

被引:10
|
作者
Wu, YC [1 ]
Liu, ZH [1 ]
Hu, WX [1 ]
Li, LS [1 ]
机构
[1] Nanjing Univ, Sch Med, Dept Med, Nanjing 210002, Peoples R China
关键词
Aristolochic Acid Nephropathy; macrophages; mast cells; myofibroblasts; renal fibrosis; toxicological pathology;
D O I
10.1191/0960327105ht502oa
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Aristolochic Acid Nephropathy (AAN) is regarded as a kind of toxic nephropathy caused by the formation of DNA- aristolochic acid adducts in renal parenchymal cells. However, the underlying mechanisms driving the progression of renal interstitial fibrosis in AAN still remains unclear. This study aims to elucidate the role of some immunological factors, especially mast cells (MCs), in the pathogenesis of AAN. Sixteen patients with AAN were enrolled in this study, including five acute and 11 chronic AAN. Monoclonal antibodies against human tryptase, alpha smooth muscle actin (alpha-SMA), and CD68 were applied on serial sections, which were further counterstained with Periodic Acid-Schiff. It was found that massive tryptase-positive MCs were observed in the fibrotic areas in chronic AAN, especially around thickened tubular basement membranes where myofibroblasts accumulated too. In contrast, MCs infiltrated to a less extent in acute AAN, and were barely found in normal control kidneys. In chronic AAN, the number of MCs in the tubulointerstitium was positively correlated with the degree of renal fibrosis (r = 0.64, P < 0.05), but not with serum creatinine levels. Meanwhile, the recruitment of MCs into the renal interstitium is accompanied with local proliferation of myofibroblasts. Macrophages were not abundant, neither in acute nor in chronic AAN. Our findings show for the first time that mast cell infiltration seems to be associated with the progression of fibrosis in the renal tubulointerstitium in chronic AAN.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 48 条
  • [1] Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy
    Sun, Dong
    Feng, Jiangmin
    Dai, Chun
    Sun, Li
    Jin, Tao
    Ma, Jianfei
    Wang, Lining
    AMERICAN JOURNAL OF NEPHROLOGY, 2006, 26 (04) : 363 - 371
  • [2] Transitional cell carcinoma associated with aristolochic acid nephropathy: most common cancer in chronic hemodialysis patients in China
    Zhou Li
    Cao Ya-li
    Li Wen-ge
    Fu Fang-ting
    Zhang Ling
    Wang Xiang
    Shi Xiao-hu
    CHINESE MEDICAL JOURNAL, 2012, 125 (24) : 4460 - 4465
  • [3] An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney Fibrosis
    Roediger, Ben
    Lee, Quintin
    Tikoo, Shweta
    Cobbin, Joanna C. A.
    Henderson, James M.
    Jormakka, Mika
    O'Rourke, Matthew B.
    Padula, Matthew P.
    Pinello, Natalia
    Henry, Marisa
    Wynne, Maria
    Santagostino, Sara F.
    Brayton, Cory F.
    Rasmussen, Lorna
    Lisowski, Leszek
    Tay, Szun S.
    Harris, David C.
    Bertram, John F.
    Dowling, John P.
    Bertolino, Patrick
    Lai, Jack H.
    Wu, Wengen
    Bachovchin, William W.
    Wong, Justin J-L
    Gorrell, Mark D.
    Shaban, Babak
    Holmes, Edward C.
    Jolly, Christopher J.
    Monette, Sebastien
    Weninger, Wolfgang
    CELL, 2018, 175 (02) : 530 - +
  • [4] Mast Cell Infiltration Is Involved in Renal Interstitial Fibrosis in a Rat Model of Protein-Overload Nephropathy
    Li, Ying
    Zhou, Letian
    Liu, Fuyou
    Peng, Youming
    Li, Jun
    Sun, Lin
    Duan, Shaobin
    Ling, Guanghui
    Chen, Xin
    Jiang, Wenling
    Xia, Yuncheng
    KIDNEY & BLOOD PRESSURE RESEARCH, 2010, 33 (03) : 240 - 248
  • [5] Mast cells and tubulointerstitial fibrosis in patients with ANCA-associated glomerulonephritis
    S. Otsubo
    K. Nitta
    K. Uchida
    W. Yumura
    H. Nihei
    Clinical and Experimental Nephrology, 2003, 7 (1) : 41 - 47
  • [6] Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice
    Dai, Xiao Y.
    Huang, Xiao R.
    Zhou, Li
    Zhang, Lin
    Fu, Ping
    Manthey, Carl
    Nikolic-Paterson, David J.
    Lan, Hui Y.
    ONCOTARGET, 2016, 7 (10): : 10841 - 10856
  • [7] Renal Mast Cell-Specific Proteases in the Pathogenesis of Tubulointerstitial Fibrosis
    Atiakshin, Dmitrii
    Morozov, Sergey
    Dlin, Vladimir
    Kostin, Andrey
    Volodkin, Artem
    Ignatyuk, Michael
    Kuzovleva, Galina
    Baiko, Sergey
    Chekmareva, Irina
    Chesnokova, Svetlana
    Elieh-Ali-Komi, Daniel
    Buchwalow, Igor
    Tiemann, Markus
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2024, 72 (8-9) : 495 - 515
  • [8] Mechanism of chronic aristolochic acid nephropathy: role of Smad3
    Zhou, Li
    Fu, Ping
    Huang, Xiao Ru
    Liu, Fei
    Chung, Arthur C. K.
    Lai, Kar Neng
    Lan, Hui Yao
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2010, 298 (04) : F1006 - F1017
  • [9] Smad7 protects against chronic aristolochic acid nephropathy in mice
    Dai, Xiao-Yu
    Zhou, Li
    Huang, Xiao-Ru
    Fu, Ping
    Lan, Hui-Yao
    ONCOTARGET, 2015, 6 (14) : 11930 - 11944
  • [10] Tissue-resident natural killer cells exacerbate tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in a model of aristolochic acid-induced nephropathy
    Wee, Yu Mee
    Go, Heounjeong
    Choi, Monica Young
    Jung, Hey Rim
    Cho, Yong Mee
    Kim, Young Hoon
    Han, Duck Jong
    Shin, Sung
    BMB REPORTS, 2019, 52 (09) : 554 - 559